Consistent with the findings of in vitro and in vivo experiments, an increase in the number of circulating or tumor-infiltrating MDSCs was associated with a decrease in the number of tumor-infiltrating CD8+ T cells [29,31,35]. The gene discussed is CD8A; the disease is neoplasm.